Ingredient or product comparison
Does GHK-Cu Help Antioxidant Research: Study Design Comparison
Researchers approach GHK-Cu from multiple angles depending on whether they're investigating enzyme kinetics, gene expression, cellular protection, or tissue-level outcomes. The table below summarizes the most common experimental designs and their reported outc
This source-based comparison does not add ratings or recommend a winner.
- Researchers approach GHK-Cu from multiple angles depending on whether they're investigating enzyme kinetics, gene expression, cellular protection, or tissue-level outcomes. The table below summarizes the most common experimental designs and their reported outcomes.
- Human fibroblast culture (in vitro)
- 10 µM, 48-hour exposure
- SOD1 enzyme activity via colorimetric assay
- 45% increase vs untreated control
- GHK-Cu reliably upregulates SOD in standard cell culture. Dose-dependent and reproducible
- UVA-irradiated skin explants (ex vivo)
- 50 µM applied topically before UVA
- 8-oxo-dG (DNA oxidative damage marker)
- 34% reduction in oxidative DNA lesions
- Pre-treatment with GHK-Cu enhances endogenous antioxidant response to exogenous stressors
- Aged Wistar rats (in vivo)
- 10 mg/kg, subcutaneous, 3× weekly for 8 weeks
- Plasma malondialdehyde and liver catalase activity
- 26% lower lipid peroxidation, 31% higher catalase
- Systemic delivery produces measurable antioxidant effects across multiple tissues
- Copper-deficient fibroblasts (in vitro)
- 5 µM, 24-hour exposure
- Time to restore baseline SOD activity
- Restored within 24 hours (vs 72 hours with copper sulfate alone)
- GHK delivers bioavailable copper more efficiently than inorganic copper salts
- Nrf2 translocation assay (in vitro)
- 10 µM, 6-hour exposure
- Nuclear Nrf2 levels via immunoblot
- 2.8-fold increase in nuclear Nrf2
- GHK-Cu activates the Nrf2-ARE pathway, inducing broad antioxidant gene expression
- H₂O₂-stressed keratinocytes (in vitro)
- 10 µM pre-treatment, 12 hours before 200 µM H₂O₂
- Apoptosis rate via annexin V staining
- Apoptosis reduced from 60% to 22%
- GHK-Cu protects against oxidative apoptosis when cells are pre-conditioned
- What this comparison reveals is that GHK-Cu's antioxidant effects are consistent across experimental models but require dose optimization for each context. A concentration effective in fibroblast culture may be insufficient in tissue explants due to diffusion barriers. Systemic studies require significantly higher doses to achieve plasma levels comparable to in vitro effective concentrations.